Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?

Time-to-event end points are the most frequent primary end points in phase III oncology trials, both in the adjuvant and advanced settings. The evaluation of these end points is important to inform clinical practice. However, although different measures can be used to describe the effect of treatmen...

Full description

Bibliographic Details

Published in:	JNCI : Journal of the National Cancer Institute Vol. 110; no. 3; p. 232
Main Authors:	Saad, Everardo D, Zalcberg, John R, Péron, Julien, Coart, Elisabeth, Burzykowski, Tomasz, Buyse, Marc
Format:	Journal Article
Language:	English
Published:	United States 01.03.2018
Subjects:	Clinical Trials as Topic - standards Humans Neoplasms - mortality Neoplasms - therapy Outcome Assessment (Health Care) - standards Prognosis Research Design - standards Survival Rate
ISSN:	1460-2105, 1460-2105
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!